课题基金 / 基金详情

EXPLOITATION OF NEW DIAGNO-THERAPEUTIC PROCEDURES OF HUMAN UTERINE ENDOCERVICAL AND ENDOMETRIAL ADENOCARCINOMAS BASED ON CYTOGENETIC STUDY OF MULTI- STEP CARCINOGENESIS

EXPLOITATION OF NEW DIAGNO-THERAPEUTIC PROCEDURES OF HUMAN UTERINE ENDOCERVICAL AND ENDOMETRIAL ADENOCARCINOMAS BASED ON CYTOGENETIC STUDY OF MULTI- STEP CARCINOGENESIS
基于多步致癌作用的细胞遗传学研究开发人类子宫内膜癌和子宫内膜腺癌的新诊断治疗方法
批准号:
14571599
负责人:
HIRAI Yasuo
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

HIRAI Yasuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We analyzed the mutational status of the TGF βRII, BAX, and PTEN/MMAC1 genes as well as microsatellite instability (MI) in consecutive cases of endocervical and endometrial adenocarcinomas of the uterus operated on at our Institute. To examine copy number losses and/or amplifications at the chromosomal region bearing all the genes, we used comparative genomic hybridization (CGH) analysis (both conventional and array-based). CGH analysis provides a genome-wide overview about tumor-associated genomic imbalances. Among the tumors, a few showed the MI+ phenotype in endocervical adenocarcinoma. Also, few tumors demonstrated a significant mutation with a definite amino acid change in PTEN/MMAC1 gene, which is prominent in endometrial adenocarcinoma. CGH analysis demonstrated several promising oncogenes which may have a role in multi-step carcinogenesis of uterine endocervical and endometrial adenocarcinomas.Additional explorations are needed to elucidate the cytogenetic mechanisms of multi- step carcinogenesis in endocervical and endometrial adenocarcinomas of the uterus.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
A large-scale gene expression comparison of microdissected small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue.
对显微解剖的小尺寸子宫内膜癌(伴或不伴增生)与同一患者正常组织进行大规模基因表达比较。
DOI: --
发表时间: 2003
期刊: Clin Cancer Res 9
影响因子: --
作者: [Sugiyama, Y., et al.]
通讯作者: et al.
Sugiyama Y, Hirai Y, et al.: "A large-scale gene expression comparison of microdissected, small-sized endometrial cancers with or without hyperplasia matched to same-patient normal tissue."Clin Cancer Res.. 15. 5589-5600 (2003)
Sugiyama Y、Hirai Y 等人:“对有或没有增生的显微解剖小尺寸子宫内膜癌与同一患者正常组织相匹配的大规模基因表达比较。”Clin Cancer Res.. 15. 5589-5600 (
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tabata T, Hirai Y, et al.: "A randomized study or primary bleomycin, vincristine, mitornycin and cisplatin(BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix."Anticancer Res..
Tabata T、Hirai Y 等人:“针对 IIIB 期和 IVA 期宫颈鳞状细胞癌进行原发博来霉素、长春新碱、丝裂霉素和顺铂 (BOMP) 化疗后放疗与单独放疗的随机研究。”Anticancer Res..
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Conventional and array-based comparative genomic hybridization analyzes of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix.
对来自宫颈玻璃细胞癌的携带 HPV18 的新型细胞系进行常规和基于芯片的比较基因组杂交分析。
DOI: --
发表时间: 2004
期刊: Int J Oncol. Apr;24(4)
影响因子: --
作者: [Hirai Y, Kawamata Y, Takeshima N, Furuta R, Kitagawa T, Kawaguchi T, Hasumi K, Sugai S, Noda T.]
通讯作者: Noda T.
19
    EXPLOITATION OF NEW DIAGNO-THERAPEUTIC PROCEDURES OF HUMAN UTERINE CANCER BASED ON MOLECULAR CYTOGENETIC STUDY
    • 批准号:
      17591770
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.39万
    • 财政年份:
      2005
    • 负责人:
      HIRAI Yasuo
    • 依托单位:
    EXPLOITATION OF NEW DIAGNO-THERAPEUTIC PROCEDURES OF HUMAN ENDOCERVICAL ADENOCARCINOMA OF THE UTERUS BASED ON CYTOGENETIC MECHANISMS OF MULTI- STEP CARCINOGENESIS
    • 批准号:
      12671643
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2000
    • 负责人:
      HIRAI Yasuo
    • 依托单位:
    EXLPLOITATION OF NEW DIAGNOSTIC PROCEDURES OF HUMAN ENDOMETRIAL CANCERS IN RELATION TO CYTOGENETIC MECHANISMS OF MULTI-STEP CARCINOGENESIS ELUCIDATED WITH CGH
    • 批准号:
      09671726
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1997
    • 负责人:
      HIRAI Yasuo
    • 依托单位:
    海外基金